Marcus L Elias, Joshua Burshtein, Victoria R Sharon
{"title":"梅克尔细胞癌原发部位和总生存率:头颈部肿瘤的预后指标","authors":"Marcus L Elias, Joshua Burshtein, Victoria R Sharon","doi":"10.25251/skin.8.3.6","DOIUrl":null,"url":null,"abstract":"Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine tumor. Primarily affecting the elderly, the incidence of MCC is 0.10 to 1.6 cases per 100,000 people per year. 1 MCC has a low overall survival (OS), ranging between 37 and 74% at 5 years. 1–5 The majority of lesions occur on the head and neck followed by the trunk and extremities","PeriodicalId":22013,"journal":{"name":"SKIN The Journal of Cutaneous Medicine","volume":"40 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Merkel cell carcinoma primary sites and overall survival: The prognostic indications of head and neck tumors\",\"authors\":\"Marcus L Elias, Joshua Burshtein, Victoria R Sharon\",\"doi\":\"10.25251/skin.8.3.6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine tumor. Primarily affecting the elderly, the incidence of MCC is 0.10 to 1.6 cases per 100,000 people per year. 1 MCC has a low overall survival (OS), ranging between 37 and 74% at 5 years. 1–5 The majority of lesions occur on the head and neck followed by the trunk and extremities\",\"PeriodicalId\":22013,\"journal\":{\"name\":\"SKIN The Journal of Cutaneous Medicine\",\"volume\":\"40 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SKIN The Journal of Cutaneous Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25251/skin.8.3.6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SKIN The Journal of Cutaneous Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25251/skin.8.3.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Merkel cell carcinoma primary sites and overall survival: The prognostic indications of head and neck tumors
Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine tumor. Primarily affecting the elderly, the incidence of MCC is 0.10 to 1.6 cases per 100,000 people per year. 1 MCC has a low overall survival (OS), ranging between 37 and 74% at 5 years. 1–5 The majority of lesions occur on the head and neck followed by the trunk and extremities